Radiotherapy News and Research

RSS
Radiation therapy (in North America), or radiotherapy (in the UK and Australia) also called radiation oncology, and sometimes abbreviated to XRT, is the medical use of ionizing radiation as part of cancer treatment to control malignant cells (not to be confused with radiology, the use of radiation in medical imaging and diagnosis).
Study finds significant variability in treatment access for patients with malignant pleural mesothelioma

Study finds significant variability in treatment access for patients with malignant pleural mesothelioma

'Cold' tumors can be turned 'hot' with extremely low doses of radiation, study shows

'Cold' tumors can be turned 'hot' with extremely low doses of radiation, study shows

Study: Nearly one in five patients with malignant pleural mesothelioma contracted COVID-19

Study: Nearly one in five patients with malignant pleural mesothelioma contracted COVID-19

Simple, non-invasive tool obviates unnecessary surgery in patients with colorectal cancer

Simple, non-invasive tool obviates unnecessary surgery in patients with colorectal cancer

First-in-human trial proves feasibility of Temporally Feathered Radiation Therapy

First-in-human trial proves feasibility of Temporally Feathered Radiation Therapy

DNMT2/TRDMT1 gene knockout may potentiate adverse effects related to drug-induced senescence

DNMT2/TRDMT1 gene knockout may potentiate adverse effects related to drug-induced senescence

New PULSAR radiation-therapy strategy achieves better tumor control

New PULSAR radiation-therapy strategy achieves better tumor control

New clinical trial investigates aspirin as part of new treatment for triple negative breast cancer

New clinical trial investigates aspirin as part of new treatment for triple negative breast cancer

COVID-19 lockdowns had minimal impact on medical treatments for Australian cancer patients

COVID-19 lockdowns had minimal impact on medical treatments for Australian cancer patients

Gateway for Cancer Research funds EORTC 1634-BTG trial in post-pubertal brain tumor patients

Gateway for Cancer Research funds EORTC 1634-BTG trial in post-pubertal brain tumor patients

Researchers develop ovarian tumor microenvironment-chip to test novel ways to treat the disease

Researchers develop ovarian tumor microenvironment-chip to test novel ways to treat the disease

Study shows promise of combining radiation therapy with dendritic-cell vaccines for breast cancer

Study shows promise of combining radiation therapy with dendritic-cell vaccines for breast cancer

Multimodality therapy critical for treating more aggressive prostate cancers

Multimodality therapy critical for treating more aggressive prostate cancers

Flinders University trial to evaluate new blood test for personalized cancer treatment

Flinders University trial to evaluate new blood test for personalized cancer treatment

Research shines new light on deadly medulloblastoma metastases

Research shines new light on deadly medulloblastoma metastases

Tips of cancer survivors' tongues are less sensitive to tastes, study finds

Tips of cancer survivors' tongues are less sensitive to tastes, study finds

FLASH radiotherapy could revolutionize future tumor treatments

FLASH radiotherapy could revolutionize future tumor treatments

New breakthrough could lead to a cure for common childhood cancer

New breakthrough could lead to a cure for common childhood cancer

New platform can detect microRNA-205 with high sensitivity, excellent selectivity

New platform can detect microRNA-205 with high sensitivity, excellent selectivity

Study provides treatment options for children with average risk medulloblastoma

Study provides treatment options for children with average risk medulloblastoma

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.